Effects of sub-chronic cannabis smoke exposure on inflammatory markers in serum and brain in younger and older mice
- 27 May 2026
- journal article
- Published by Elsevier in Neurobiology of Aging
- Vol. 166, 58-68
Abstract
No abstract availableKeywords
Funding Information
- Florida Department of Health
- National Institute on Aging
- Evelyn F. McKnight Brain Research Foundation
This publication has 48 references indexed in Scilit:
- Trends in Past-Month Cannabis Use Among Older AdultsJAMA Internal Medicine, 2025
- Effects of cannabis smoke and oral Δ9THC on cognition in young adult and aged ratsPsychopharmacology, 2025
- Medical Cannabis Use Among Older Adults in Canada: Self-Reported Data on Types and Amount Used, and Perceived EffectsDrugs & Aging, 2021
- Current Aspects of the Endocannabinoid System and Targeted THC and CBD Phytocannabinoids as Potential Therapeutics for Parkinson’s and Alzheimer’s Diseases: a ReviewMolecular Neurobiology, 2020
- Inflammatory Markers Change with Age, but do not Fall Beyond Reported Normal RangesArchivum Immunologiae et Therapiae Experimentalis, 2015
- Analysis of serum cytokine/chemokine profiles affected by aging and exercise in miceCytokine, 2012
- Aging is associated with circulating cytokine dysregulationCellular Immunology, 2012
- Intra-individual variability over time in serum cytokine levels among participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening TrialCytokine, 2011
- Quantitation of proteins using a dye–metal-based colorimetric protein assayAnalytical Biochemistry, 2009
- The Cannabinoid Delta-9-tetrahydrocannabinol Mediates Inhibition of Macrophage Chemotaxis to RANTES/CCL5: Linkage to the CB2 ReceptorJournal of Neuroimmune Pharmacology, 2007